Theme of Dr. Gordan Lauc at the Longevity Med Summit – IgG glycans are biomarkers and modifiable functional effectors of disease risk
Gordan Lauc is Professor of Biochemistry and Molecular Biology at the University of Zagreb Faculty of Pharmacy and Biochemistry. His laboratory performed the first large scale studies of the human plasma glycome (in 2009) and human IgG glycome (in 2011), which were the basis for the subsequent first GWAS of the human plasma and IgG glycomes. He was invited to lecture at numerous international conferences (including FEBS, EMBO, ASBMB, Glyco, etc), elected for visiting professor at the Johns Hopkins University, University of Edinburgh and Edith Cowan University in Perth. In 2011 he was inducted in the prestigious John Hopkins Society of Scholars. In 2007 Prof Lauc established Genos Ltd., a private research organisation accredited by the Croatian Ministry of Science, Education and Sport that currently has 28 employees, including 17 researchers. Genos was ranked as ranked as #1 in the 2013 survey of the Scientist magazine for “The best place to work for researches” in the category “Industry” and received a Charter of the Republic of Croatia (awarded by the President of Croatia) for an outstanding economic contribution to development of Croatia by commercialization of research results in 2014.